Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cells

Biochemical Pharmacology

Volumn 71, Issue 1-2, 2005, Pages 32-41

  Soto Cerrato, Vanessa ^a   Montaner, Beatriz ^a   Martinell, Marc ^a   Vilaseca, Marta ^a   Giralt, Ernest ^a   Pérez Tomás, Ricardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Caspases; Cell cycle arrest; Depsipeptide; p53

Indexed keywords

ANTINEOPLASTIC AGENT; AT 514; CYCLODEPSIPEPTIDE; SERRATAMOLIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; WILD TYPE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; DEPSIPEPTIDES; ENZYME ACTIVATION; HUMANS; INTRACELLULAR MEMBRANES; MITOCHONDRIA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 28244496569     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.10.020     Document Type: Article

References (33)

1. C.E. Ballard, H. Yu, and B. Wang Recent developments in depsipeptide research Curr Med Chem 9 2002 471 498
2. H. Hochster, R. Oratz, D. Ettinger, and E. Borden A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern cooperative oncology group study (PB687) Invest New Drugs 16 1999 259 263
3. A.P. Brown, R.L. Morrissey, G.T. Faircloth, and B.S. Levine Preclinical toxicity studies of Kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat Cancer Chemother Pharmacol 50 2002 333 340
4. K.A. Fecteau, J. Mei, and H.C. Wang Differential modulation of signaling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228 J Pharmacol Exp Ther 300 2002 890 899
5. D. Green Apoptotic pathways: the roads to ruin Cell 94 1998 695 698
6. S. Cory, and J. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat Rev Cancer 2 2002 647 656
7. G. Salvesen, and V. Dixit Caspases: intracellular signaling by proteolysis Cell 91 1997 443 446
8. G. Kroemer, and J. Reed Mitochondrial control of cell death Nat Med 6 2000 513 519
9. M. Los, C.J. Burek, C. Stroh, K. Benedyk, H. Hug, and A. Mackiewicz Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design Drug Discov Today 8 2003 67 77
10. D. Fisher Apoptosis in cancer therapy: crossing the threshold Cell 78 1994 539 542
11. T. Matsuyama, A. Bhasin, and R. Harshey Mutational analysis of glagellum-independent surface spreading of Serratia marcescens 274 on a low-agar medium J Bacteriol 177 1995 987 991
12. Y. Miyazaki, S. Oka, H. Hara-Hotta, and I. Yano Stimulation and inhibition of polymorphonuclear leukocytes phagocytosis by lipoamino acids isolated from Serratia marcescens FEMS Immunol Med Microbiol 6 1993 265 272
13. C.H. Hassal, M.C. Moschidis, and W.A. Thomas The conformations of serratamolide and related cyclotradepsipeptides in solution J Chem Soc (B) 1971 1757 1761
14. P. Branch, M. Masson, G. Aquilina, M. Bignami, and P. Karran Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells Oncogene 28 2000 3138 3145
15. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Meth 65 1983 55 63
16. S. Kasibhatla, and B. Tseng Why target apoptosis in cancer treatment? Mol Cancer Ther 2 2003 573 580
17. F. Sarabia, S. Chamma, A.S. Ruiz, L.M. Ortiz, and J.L. Herrera Chemistry and biology of cyclic depsipeptides of medicinal and biological interest Curr Med Chem 11 2004 1309 1332
18. J.C. Byrd, C. Shinn, R. Ravi, C.R. Willis, J.K. Waselenko, and I.W. Flinn Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells Blood 94 1999 1401 1408
19. D. Klisovic, S. Katz, D. Effron, M.I. Klisovic, J. Wickham, and M.R. Parthun Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines Ophthalmol Vis Sci 44 2003 2390 2398
20. H. Fujiwara, T. Yamakuni, M. Ueno, M. Ishizuka, T. Shinkawa, and T. Isobe IC101 induces apoptosis by Akt dephosphorylation via an inhibition of heat shock protein 90-ATP binding activity accompanied by preventing the interaction with Akt in L1210 cells J Pharmacol Exp Ther 310 2004 1288 1295
21. S. Cory, and J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat Rev Cancer 2 2002 647 656
22. Q.H. Hou, S.C. Cymbalyuk, M. Hsu, and Y.T. Hsu Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome c release and Bax regulation Apoptosis 8 2003 617 629
23. L in cancer cells by a novel small molecule, 2[[3-(2,3-dichlorophenoxy)propyl]amino] ethanol Cancer Res 64 2004 1110 1113
24. S.J. Korsmeyer, M.C. Wei, M. Saito, S. Weiler, K.J. Oh, and P.H. Schlesinger Proapoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c Cell Death Differ 7 2000 1166 1173
25. M.J. Peart, K.M. Tainton, A.A. Ruefli, A.E. Dear, K.A. Sedelies, and L.A. O'Reilly Novel mechanisms of apoptosis induced by histone deacetylase inhibitors Cancer Res 63 2003 4460 4471
26. S.P. Cregan, V.L. Dawson, and R.S. Slack Role of AIF in caspase-dependent and caspase-independent cell death Oncogene 23 2004 2785 2796
27. H. Liang, R.A. Salinas, B.Z. Leal, T. Kosakowska-Cholody, C.J. Michejda, and S.J. Waters Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells Mol Cancer Ther 3 2004 1385 1396
28. Y. Suarez, L. Gonzalez, A. Cuadrado, M. Berciano, M. Lafarga, and A. Muñoz Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells Mol Cancer Ther 2 2003 863 872
29. J.L. Aron, M.R. Parthun, G. Marcucci, S. Kitada, A.P. Mone, and M.E. Davis Depsipeptide FR901228 induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase-8-mediated apoptosis and down-regulation of c-FLIP protein Blood 102 2003 652 658
30. E. Escobar-Díaz, E.M. López-Martín, M. Hernández del Cerro, A. Puig-Kroger, V. Soto-Cerrato, and B. Montaner AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway Leukemia 19 4 2005 572 579
31. S.W. Lowe, H.E. Ruley, T. Jacks, and D.E. Housman p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957 967
32. R.U. Janicke, M.L. Sprengart, M.R. Wati, and A.G. Porter Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis J Biol Chem 273 1998 9357 9360
33. K. Sasai, H. Yajima, and F. Suzuki Suppression of postmitochondrial signaling and delayed response to UV-induced nuclear apoptosis in HeLa cells Jpn J Cancer Res 93 2002 275 283